Second-line therapy for patients with relapsing-remitting multiple sclerosis a review of guidelines
There is uncertainty in clinical practice regarding how and when to switch from the first-line therapy to a second-line therapy for relapsing-remitting multiple sclerosis (RRMS). This review seeks to report on the critically appraisal of the evidence-based guidelines regarding switching to a second-...
Main Authors: | , |
---|---|
Corporate Authors: | , |
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
CADTH
2019, September 26, 2019
|
Series: | CADTH rapid response report: summary with critical appraisal
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references